Arterial Stiffness and Ambulatory Blood Pressure Measurements in Children With Familial Mediterranean Fever.
Ayça Burcu KahramanBahar BüyükkaragözEmine Nur Sunar YaylaPelin Esmeray ŞenolSevcan A BakkaloğluPublished in: Clinical pediatrics (2023)
Familial Mediterranean fever (FMF) is an autoinflammatory disease which may cause endothelial dysfunction and arterial stiffness. In this study, we evaluated patients with FMF in terms of arterial stiffness indicators and investigated whether there was any difference according to colchicine response. This is a single-center, prospective, case-control study conducted on pediatric patients with FMF. Patients were categorized into 2 groups: patients on colchicine monotherapy (group 1) and patients who used anti-interleukin-1 (IL-1) plus colchicine (group 2). Patient age, mutations in the MEFV gene, overall duration of treatments, and general characteristics of symptoms were recorded. Laboratory values in an attack-free period were noted. Pulse wave velocity (PWV) was measured in all patients. Erythrocyte sedimentation rate and C-reactive protein, nocturnal hypertension, and PWV were higher in group 2. Arterial stiffness develops due to subclinical inflammation in patients with FMF. It is more pronounced in colchicine-resistant patients.
Keyphrases
- blood pressure
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- obstructive sleep apnea
- type diabetes
- randomized controlled trial
- oxidative stress
- depressive symptoms
- physical activity
- dna methylation
- open label
- high resolution
- genome wide
- combination therapy
- skeletal muscle
- patient reported
- high speed
- blood flow
- genome wide identification